Utilization of Staging Laparoscopy for Patients With Gastric Cancer in Ukraine
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.28095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Oleksii Dobrzhanskyi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Upper Gastrointestinal Oncology, National Cancer Institute, Kyiv, Ukraine. Hauptthemen laut MEDLINE: Stomach Neoplasms, Laparoscopy, Peritoneal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: The study was performed within governmental funding for the National Cancer Institute..
Abstract (Originalsprache)
Background
The use of advanced diagnostic methods, such as high‐resolution CT or PET‐CT scans, are limited in low and middle‐income countries (LMICs). In gastric cancer, occult peritoneal disease may be present in up to 20% of cases, limiting the benefits of surgical resection. Accurate staging of gastric cancer is essential to ensure optimal patient management and prevent undue morbidity from unnecessary surgery. Our study evaluated the diagnostic accuracy and safety of staging laparoscopy (SL) versus computed tomography (CT) in detecting peritoneal metastases for gastric cancer in Ukraine.
Methods
Patients who underwent SL between October 2017 and October 2022 were retrospectively reviewed. SL was performed for each newly diagnosed patient with gastric cancer without evidence of distant metastases, except when peritoneal carcinomatosis was in question. Pathological findings at SL were compared with initial CT reports, and analysis of the sensitivity and specificity for SL was performed.
Results
Of 516 patients undergoing SL, 410 had no radiological considerations for distant metastases. Among them, radiographically occult peritoneal metastatic disease was found in 134 (32.7%). Overall SL sensitivity for peritoneal metastases was 90.6% (95% confidence interval [CI]: 85.8%–94.1%) and specificity 100.0% (95% CI: 98.8%–100.0%). Complications after SL occurred in 5 (1%) of patients. No mortality was associated with SL.
Conclusion
SL is a safe and effective method to evaluate the presence of peritoneal disease in patients with gastric cancer. This method may be appropriate for LMICs, where availability of advanced imaging technologies is limited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Upper Gastrointestinal Oncology, National Cancer Institute, Kyiv, Ukraine.
- Department of Surgery, Center for Global Surgery, University of California Davis, Sacramento, California, USA.
- Division of Cancer Medicine, Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Oleksii Dobrzhanskyi, Yurii Kondratskyi, Andrii Horodetskyi, Mykyta Pepenin
Förderung
- The study was performed within governmental funding for the National Cancer Institute.
Zitieren
APA
Dobrzhanskyi, O., Gaskill, C. E., Kizub, D., Kondratskyi, Y., Horodetskyi, A., Melnitchouk, N., & Pepenin, M. (2025). Utilization of Staging Laparoscopy for Patients With Gastric Cancer in Ukraine. Journal of Surgical Oncology. https://doi.org/10.1002/jso.28095
Vancouver
Dobrzhanskyi O, Gaskill CE, Kizub D, Kondratskyi Y, Horodetskyi A, Melnitchouk N, et al. Utilization of Staging Laparoscopy for Patients With Gastric Cancer in Ukraine. Journal of Surgical Oncology. 2025. doi:10.1002/jso.28095
BibTeX
@article{Dobrzhanskyi2025,
author = {Dobrzhanskyi, Oleksii and Gaskill, Cameron E and Kizub, Darya and Kondratskyi, Yurii and Horodetskyi, Andrii and Melnitchouk, Nelya and Pepenin, Mykyta},
title = {Utilization of Staging Laparoscopy for Patients With Gastric Cancer in Ukraine},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.28095}
}
EUVIMED